or
forgot password
  • cancer clinical trials in norwalk, CT

  • Radiation Therapy in Treating Patients With Stage II or Stage III Prostate Cancer
    Whittingham Cancer Center
    Norwalk, Connecticut 06856
    Prostate Cancer
    Pilocarpine in Preventing Mucositis and Dry Mouth in Patients Receiving Radiation Therapy for Head and Neck Cancer
    Whittingham Cancer Center
    Norwalk, Connecticut 06856
    Head and Neck Cancer, Oral Complications
    Irinotecan With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer
    Whittingham Cancer Center
    Norwalk, Connecticut 06856
    Colorectal Cancer
    Docetaxel With or Without Oblimersen in Treating Patients With Non-Small Cell Lung Cancer
    Whittingham Cancer Center
    Norwalk, Connecticut 06856
    Lung Cancer
    Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
    Whittingham Cancer Center at Norwalk Hospital
    Norwalk, Connecticut 06856
    Breast Cancer
    PANVAC™-VF Vaccine for the Treatment of Metastatic Pancreatic Cancer After Failing a Gemcitabine-Containing Regimen
    Norwalk Hospital/ Whittingham Cancer Center
    Norwalk, Connecticut 06856
    Pancreatic Cancer
    Erlotinib or Placebo Following Chemoradiotherapy (Chemo/RT) in Stage III Non-Small Cell Lung Cancer (NSCLC)
    Whittingham Cancer Center at Norwalk Hospital
    Norwalk, Connecticut 06856
    Carcinoma, Non-Small-Cell Lung, Non-small Cell Lung Cancer, NSCLC
    Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
    Norwalk Hospital
    Norwalk, Connecticut 06856
    Adenocarcinoma of the Colon, Stage II Colon Cancer
    Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    Norwalk Hospital
    Norwalk, Connecticut 06856
    Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Stage III Ovarian Epithelial Cancer, Stage IV Ovarian Epithelial Cancer
    Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
    Norwalk Hospital
    Norwalk, Connecticut 06856
    Stage IB Non-small Cell Lung Cancer, Stage IIA Non-small Cell Lung Cancer, Stage IIB Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer
    Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
    Norwalk Hospital
    Norwalk, Connecticut 06856
    Male Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer
    Efficacy Study of Oral Sapacitabine to Treat Acute Myeloid Leukemia in Elderly Patients
    Nowalk Hospital
    Norwalk, Connecticut 06856
    Acute Myeloid Leukemia
    Fludarabine and Rituximab With or Without Lenalidomide or Cyclophosphamide in Treating Patients With Symptomatic Chronic Lymphocytic Leukemia
    Norwalk Hospital
    Norwalk, Connecticut 06856
    B-cell Chronic Lymphocytic Leukemia, Stage I Chronic Lymphocytic Leukemia, Stage II Chronic Lymphocytic Leukemia, Stage III Chronic Lymphocytic Leukemia, Stage IV Chronic Lymphocytic Leukemia
    Safety and Exploratory Efficacy of Kanglaite Injection in Pancreatic Cancer
    Norwalk Hospital
    Norwalk, Connecticut 06856
    Pancreatic Cancer
    Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed By Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery
    Norwalk Hospital
    Norwalk, Connecticut 06856
    Estrogen Receptor-negative Breast Cancer, HER2-negative Breast Cancer, Male Breast Cancer, Progesterone Receptor-negative Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Triple-negative Breast Cancer
    Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
    Norwalk Hospital
    Norwalk, Connecticut 06856
    Distal Urethral Cancer, Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter, Proximal Urethral Cancer, Recurrent Bladder Cancer, Recurrent Prostate Cancer, Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter, Recurrent Urethral Cancer, Stage IV Bladder Cancer, Stage IV Prostate Cancer, Transitional Cell Carcinoma of the Bladder, Urethral Cancer Associated With Invasive Bladder Cancer
    Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination Chemotherapy
    Norwalk Hospital
    Norwalk, Connecticut 06856
    Chemotherapeutic Agent Toxicity, Colorectal Cancer, Neuropathy, Neurotoxicity
    Safety and Tolerability Study of ISIS EIF4E Rx in Combination With Docetaxel and Prednisone (CRPC)
    Norwalk Hospital- Whittingham Cancer Center
    Norwalk, Connecticut 06850
    Castrate-Resistant Prostate Cancer
    A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia
    Norwalk Hospital
    Norwalk, Connecticut 06856
    Acute Myeloid Leukemia
    A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
    Norwalk Hospital
    Norwalk, Connecticut 06856
    Advanced Prostate Cancer, Prostatic Neoplasms
    Study of Fc-Optimized Anti-CD19 Antibody (MOR00208) to Treat Non-Hodgkin´s Lymphoma (NHL)
    MorphoSys Research Site
    Norwalk, Connecticut
    Non-Hodgkin Lymphoma
    Radiation Therapy Plus Chemotherapy in Treating Patients With Supratentorial Glioblastoma Multiforme
    Whittingham Cancer Center
    Norwalk, Connecticut 06856
    Brain and Central Nervous System Tumors
    Talc in Treating Patients With Malignant Pleural Effusion
    Whittingham Cancer Center
    Norwalk, Connecticut 06856
    Metastatic Cancer
    Radiation Therapy With or Without Radiosurgery in Treating Patients With Brain Metastases
    Whittingham Cancer Center
    Norwalk, Connecticut 06856
    Metastatic Cancer
    Radiation Therapy in Treating Women With Stage I or Stage II Breast Cancer
    Whittingham Cancer Center
    Norwalk, Connecticut 06856
    Breast Cancer
    Brachytherapy in Treating Patients With Prostate Cancer
    Whittingham Cancer Center
    Norwalk, Connecticut 06856
    Prostate Cancer
    Radiation Therapy Plus Paclitaxel in Treating Patients With Nonmetastatic, Unresectable Pancreatic Cancer
    Whittingham Cancer Center
    Norwalk, Connecticut 06856
    Pancreatic Cancer
    Pentosan Polysulfate in Treating Patients With Gastrointestinal Disturbance Caused by Radiation Therapy
    Whittingham Cancer Center
    Norwalk, Connecticut 06856
    Diarrhea, Radiation Enteritis
    Radiation Therapy and Cisplatin in Treating Patients With Advanced Head and Neck Cancer
    Whittingham Cancer Center
    Norwalk, Connecticut 06856
    Head and Neck Cancer
    Docetaxel, Estramustine, and Thalidomide in Treating Patients With Prostate Cancer Previously Treated With Hormone Therapy
    Whittingham Cancer Center at Norwalk Hospital
    Norwalk, Connecticut 06856
    Prostate Cancer
    TLK286 (Telcyta) vs. Doxil/Caelyx or Hycamtin in Platinum Refractory or Resistant Ovarian Cancer
    Whittingham Cancer Center at Norwalk Hospital
    Norwalk, Connecticut 06856
    Ovarian Neoplasms
    A Study to Evaluate rhuMab 2C4 and Gemcitabine in Subjects With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
    Norwalk Medical Group
    Norwalk, Connecticut 06856
    Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer
    Study of VELCADE and Rituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma
    Norwalk Medical Group
    Norwalk, Connecticut 06856
    Non-Hodgkin's Lymphoma
    Multi-Center Human Alert Trial to Prevent DVT and PE
    Norwalk Hospital
    Norwalk, Connecticut 06856
    Pulmonary Embolism, Deep Vein Thrombosis, Cancer, Surgery
    Efficacy and Safety of Patupilone in Men (≥18 Years) With Metastatic Hormone Refractory Prostate Cancer
    Norwalk Hospital
    Norwalk, Connecticut 06856
    Metastatic Hormone Refractory Prostate Cancer
    Combination Trial of Patupilone and Carboplatin in Adult Patients With Advanced Solid Tumors
    Norwalk Hospital
    Norwalk, Connecticut 06856
    Advanced Solid Tumors
    Expanded Access Study of Satraplatin Plus Prednisone in Patients With Hormone Refractory Prostate Cancer (HRPC)
    Whittigham Cancer Center at Norwalk Hospital
    Norwalk, Connecticut 06856
    Prostate Cancer
    Assessment and Tracking of Long-term Alefacept Safety
    Bender and Kolenik MD, PC

    Trial Locations
    Bender and Kolenik MD, PC
    Charles Halasz
    Stuart Bender
    Psoriasis
    Study of CryoSpray Ablation of Low Grade or High Grade Dysplasia Within Barrett's Esophagus
    Norwalk Hospital
    Norwalk, Connecticut 06856
    Barrett's Esophagus, High Grade Dysplasia, Low Grade Dysplasia
    Safety and Efficacy Study of Switching From Epzicom to Truvada
    Blick Medical Associates
    Norwalk, Connecticut 06851
    HIV Infection